Ignite Creation Date:
2024-05-06 @ 12:53 AM
Last Modification Date:
2024-10-26 @ 10:56 AM
Study NCT ID:
NCT01684540
Status:
COMPLETED
Last Update Posted:
2012-09-24
First Post:
2012-09-11
Brief Title:
Application of Ectoin Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis
Sponsor:
Bitop AG
Organization:
Bitop AG
Study Overview
Official Title:
Non-interventional Study Application of Ectoin Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis
Status:
COMPLETED
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SNS01
Brief Summary:
This is a comparative open label parallel group non interventional study to further demonstrate the effectiveness and tolerability of Ectoin Rhinitis Nasal Spray In addition the effectiveness and safety shall be compared to a Sinupret forte The patient applies Ectoin Rhinitis Nasal Spray or takes Sinupret forte according to the instructions for use The observation takes place over a period of 14 days Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NIS SNS01 | None | None | None |